propranolol has been researched along with silodosin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Autelitano, DJ; Woodcock, EA | 1 |
| Erami, C; Faber, JE; French, DM; Ho, JG; Zhang, H | 1 |
1 review(s) available for propranolol and silodosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for propranolol and silodosin
| Article | Year |
|---|---|
Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs.
Topics: Adrenergic alpha-Agonists; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Heart; Imidazoles; Indoles; Myocardium; Propranolol; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; RNA, Messenger; Tetrahydronaphthalenes | 1998 |
Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angioplasty, Balloon; Animals; Carotid Artery Injuries; Cell Division; Idazoxan; Imines; Indoles; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxathiins; Piperazines; Piperidines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Recurrence; Tunica Intima; Vasoconstrictor Agents | 2002 |